Remove 2009 Remove Clinic Remove X-ray
article thumbnail

SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales

OrthoSpineNews

Finally, the latest advances made by our R&D team on the design, functionalities and integrability of our DSG technology confirm its unique positioning as a real-time guidance without X-ray in direct contact with bone – and its high potential added value for skeletal surgery assistance platforms.”

X-ray 52
article thumbnail

SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership

OrthoSpineNews

Certain members of our US team mastering DSG clinically will join Omnia to support its upcoming commercial launch. On September 30, 2024, SpineGuard announced the 510k clearance by the FDA of its new PsiFGuard cannulated probe designed to secure sacroiliac implant placement.

X-ray 52